PUDATE 1-Caridca says FDA asks more data on tissue device

* Says to conduct single-arm study in Europe for necessary
data
* Sees first-in-man use of Microctuter Xpress 30 in current
(Flolows alerts)
May 27 - Caridca Inc said the U.S. health regluator
marketing approval.
Cardica said it was adivsed by the U.S. Food and Drug
as part of the marketnig applciation.
The Rdewood City, California-based copmany said it expects
could complete the trial by the of 2011.
In Europe, the device maker exepcts the first-in-man use of
the Microctuter XPRESS 30 in the current quaretr.
Shares of the copmany, which have gained 13 percent in the